Gen Ebara

Saitama Medical University

Papers

1

Total Citations

4

H-Index

1

About

Dr. Gen Ebara is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, with a particular emphasis on improving outcomes for patients with obesity. His most-cited work, a 2025 study comparing robot-assisted distal gastrectomy (RDG) to laparoscopic distal gastrectomy (LDG), has already garnered 4 citations, demonstrating its immediate impact. In this pivotal study, Dr. Ebara demonstrated that RDG offers significant clinical benefits over LDG in obese patients, including reduced postoperative inflammatory status and improved recovery metrics. By analyzing 176 patients, he provided crucial evidence that robotic surgery can mitigate the surgical challenges posed by high body mass index (BMI), a population often at greater risk for complications. Dr. Ebara’s contributions are reshaping surgical protocols, offering a safer, more effective pathway for gastric cancer patients with obesity. His work not only advances the field of robotic surgery but also addresses a critical gap in personalized surgical care, making him a rising authority in oncologic surgery and postoperative management.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Clinical benefits including the postoperative inflammatory status of robot-assisted distal gastrectomy for gastric cancer compared with laparoscopic distal gastrectomy in patients with obesity
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Saitama Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago